Lipid Metabolism Practice Questions

Q: Which lipoprotein level is affected by LCAT deficiency?

HDL. ***HDL*** - **LCAT (Lecithin-cholesterol acyltransferase)** is crucial for the maturation of **HDL (High-Density Lipoprotein)**. - LCAT esterifies cholesterol in HDL, enabling it to accept more free cholesterol from peripheral tissues, thus a deficiency leads to dysfunctional and decreased mature HDL. *LDL* - **LDL (Low-Density Lipoprotein)** formation primarily involves the breakdown of VLDL and IDL by lipoprotein lipase and hepatic lipase, not directly LCAT activity. - While an LCAT deficiency can indirectly affect lipid metabolism, its direct impact on LDL levels is less pronounced compared to HDL. *VLDL* - **VLDL (Very-Low-Density Lipoprotein)** is synthesized in the liver and transports triglycerides, with its metabolism being largely independent of LCAT. - LCAT's primary role is in **reverse cholesterol transport** and HDL maturation, not VLDL synthesis or catabolism. *Chylomicron* - **Chylomicrons** are formed in the intestines and transport dietary triglycerides and cholesterol, with their metabolism involving lipoprotein lipase. - LCAT does not directly affect the synthesis or breakdown of chylomicrons, which are primarily concerned with exogenous lipid transport.

Q: What is the metabolic abnormality associated with Zellweger syndrome?

Accumulation of very long-chain fatty acids. ***Accumulation of very long-chain fatty acids*** - **Zellweger syndrome** is a peroxisomal biogenesis disorder, meaning that peroxisomes, which are responsible for the **beta-oxidation** of very long-chain fatty acids (VLCFAs), are absent or dysfunctional. - The inability to break down **VLCFAs** leads to their accumulation in various tissues, causing significant neurological and systemic dysfunction. *Accumulation of long-chain fatty acids* - While peroxisomes can contribute to the metabolism of some **long-chain fatty acids (LCFAs)**, their primary role in this context is with **VLCFAs**. - **Mitochondria** are the main organelles responsible for the beta-oxidation of most LCFAs. *Accumulation of short-chain fatty acids* - **Short-chain fatty acids (SCFAs)** are primarily produced by gut bacteria and are metabolized in the mitochondria and other cellular compartments. - Their accumulation is not characteristic of **Zellweger syndrome**. *Accumulation of medium-chain fatty acids* - **Medium-chain fatty acids (MCFAs)** are primarily metabolized in the **mitochondria** and do not typically accumulate in Zellweger syndrome. - Disorders affecting MCFA metabolism usually point to different enzyme deficiencies, such as **MCAD deficiency.**

Q: Which of the following is a lipotropic factor?

Methionine. ***Methionine*** - **Methionine** is an essential amino acid that serves as a precursor for **choline** and **creatine**, both of which play crucial roles in lipid metabolism and transport. - Lipotropic factors prevent or reverse the accumulation of **fat in the liver** by promoting the synthesis of **lipoproteins**, which package and transport fats from the liver to other tissues. *Sphingomyelin* - **Sphingomyelin** is a type of **sphingolipid**, a component of cell membranes and myelin sheaths, but it does not directly act as a lipotropic factor to prevent fatty liver. - While it's involved in cellular signaling and membrane structure, it does not directly facilitate the metabolism or transport of **hepatic triglycerides** in the same way as lipotropic agents. *Histidine* - **Histidine** is an essential amino acid involved in protein synthesis and the production of **histamine**, but it is not considered a primary lipotropic factor. - Its main roles are in **immune response** and **neurotransmission**, not in preventing fat accumulation in the liver. *Bilirubin* - **Bilirubin** is a waste product from the breakdown of **heme**, primarily from red blood cells. It is excreted by the liver. - It is known for its **antioxidant properties** but does not play a direct role as a lipotropic factor in lipid metabolism or in preventing **fatty liver**.

Q: Why is oxidized LDL considered more atherogenic?

Is taken up by scavenger receptors. ***Is taken up by scavenger receptors*** - **Oxidized LDL (oxLDL)** is taken up by **scavenger receptors (CD36, SR-A)** on macrophages, which have **no feedback regulation**. - Unlike native LDL receptors that downregulate when cells have sufficient cholesterol, **scavenger receptors continue unlimited uptake**, leading to foam cell formation. - This **unregulated uptake mechanism** is the key reason why oxLDL is **more atherogenic** than native LDL. - The result is lipid-laden macrophages forming **fatty streaks**, the initial lesions of **atherosclerosis**. *Is not recognized by LDL receptors* - While true that oxLDL has **reduced affinity** for native LDL receptors due to oxidative modification, this alone doesn't explain increased atherogenicity. - The critical factor is what happens instead—its uptake via an **alternative, unregulated pathway**. *Accumulates in macrophages* - This is a **consequence** of scavenger receptor uptake, not the primary mechanism. - Foam cell formation occurs **because** of unregulated scavenger receptor uptake, making this a downstream effect. *Promotes inflammation in arterial walls* - OxLDL does promote inflammation through multiple mechanisms (cytokine release, endothelial dysfunction). - However, this is a **secondary effect** that occurs after uptake and accumulation—not the primary reason for atherogenicity.

Q: What is the primary product of fatty acid oxidation (β-oxidation)?

Acetyl CoA. ***Acetyl CoA*** - Beta-oxidation of fatty acids involves a series of reactions that cleave two-carbon units from the fatty acyl chain, forming **acetyl CoA**. - **Acetyl CoA** is the direct product of each cycle of β-oxidation and then enters the **citric acid cycle** to generate ATP or serves as a precursor for other anabolic pathways. *Malonyl CoA* - **Malonyl CoA** is a key intermediate in **fatty acid synthesis**, not degradation. - It's formed from acetyl CoA by acetyl-CoA carboxylase and acts as a substrate for **fatty acid synthase**, and also as a physiological inhibitor of carnitine palmitoyltransferase I (CPT-I), thereby regulating β-oxidation. *Ketone bodies* - **Ketone bodies** (**acetoacetate** and **β-hydroxybutyrate**) are produced from acetyl CoA in the liver during conditions of low glucose availability or prolonged fasting. - They serve as an alternative fuel source for tissues like the brain and muscles, but are secondary products derived from the condensation of acetyl CoA molecules, not the primary direct product of fatty acid breakdown itself. *Cholesterol* - **Cholesterol** is a steroid lipid synthesized from **acetyl CoA** through a complex multi-step pathway (via HMG-CoA reductase pathway). - It is an important structural component of cell membranes and a precursor for steroid hormones and bile acids, but not a direct product of fatty acid catabolism.

Q: Which of the following is an ω-6 fatty acid?

Linoleic acid. ***Linoleic acid*** - **Linoleic acid** (LA), an 18-carbon fatty acid with two double bonds (18:2), is classified as an **ω-6 fatty acid** because its first double bond is located at the sixth carbon atom from the methyl end of the fatty acid chain. - It is an **essential fatty acid** that must be obtained through diet, serving as a precursor for other ω-6 fatty acids like arachidonic acid. *Cervonic acid* - **Cervonic acid** is another name for **docosahexaenoic acid (DHA)**, which is an **ω-3 fatty acid** (22:6). - Its first double bond is located at the third carbon from the methyl end. *Alpha linolenic acid* - **Alpha-linolenic acid** (ALA) is an **ω-3 fatty acid** (18:3). - Its first double bond is located at the third carbon atom from the methyl end. *Elaidic acid* - **Elaidic acid** is a **trans fatty acid** (18:1 trans-9). - It is classified as an **ω-9 fatty acid** due to the position of its double bond, but its trans configuration is the primary distinguishing feature.

Q: The primary site of lipogenesis is:

Liver. ***Liver*** - The **liver** is the principal organ for **de novo lipogenesis**, converting excess carbohydrates into fatty acids and triglycerides. - This process is highly active in response to a high-carbohydrate diet, with the synthesized lipids packaged into **VLDL** for transport. *Skeletal muscles* - **Skeletal muscles** primarily utilize fatty acids for **energy production** rather than synthesizing large amounts of new lipids. - While they can store some triglycerides, their capacity for de novo lipogenesis is significantly lower compared to the liver. *Myocardium* - The **myocardium** (heart muscle) primarily relies on fatty acids for its continuous **energy demands** and has limited capacity for de novo lipogenesis. - Its metabolic focus is on efficient **ATP generation** to maintain cardiac function. *Lungs* - The **lungs** are not a primary site for general lipogenesis, though they are involved in the synthesis of specific lipids like **surfactant**. - Surfactant synthesis is a specialized process crucial for lung function, distinct from general energy storage lipogenesis.

Q: Which molecule serves as the ultimate source of acetyl groups for fatty acid synthesis?

Acetyl CoA. ***Acetyl CoA*** - **Acetyl CoA** is the ultimate source of all acetyl groups used in fatty acid synthesis - It serves as the substrate for **acetyl CoA carboxylase**, which converts it to **malonyl CoA** - After transport from mitochondria via **citrate**, acetyl CoA is the precursor for all two-carbon units incorporated into fatty acids - One molecule of acetyl CoA also serves as the primer for fatty acid synthesis *Malonyl CoA* - **Malonyl CoA** is the direct two-carbon donor to the growing fatty acid chain - However, it is derived from **acetyl CoA** through carboxylation by **acetyl CoA carboxylase** - It is an intermediate, not the ultimate source of acetyl groups *Palmitate* - **Palmitate** is a 16-carbon saturated fatty acid that is the end product of de novo fatty acid synthesis - It is the product of fatty acid synthesis, not a donor of acetyl groups *Citrate* - **Citrate** transports acetyl groups from the **mitochondria** to the **cytosol** where fatty acid synthesis occurs - In the cytosol, **ATP citrate lyase** cleaves citrate back into **acetyl CoA** and oxaloacetate - Citrate is a transport vehicle, not the ultimate source of acetyl groups

Q: Which hormone inhibits hormone-sensitive lipase?

Insulin. ***Insulin*** - **Insulin** is a key anabolic hormone that promotes energy storage and inhibits catabolic processes, including the breakdown of triglycerides. - It directly inhibits **hormone-sensitive lipase (HSL)** activity, thus reducing the release of free fatty acids from adipose tissue. *Thyroid hormone* - **Thyroid hormones** (T3 and T4) generally promote catabolism and increase metabolic rate, including the mobilization of lipids. - They tend to **stimulate rather than inhibit** hormone-sensitive lipase expression and activity. *GH* - **Growth hormone (GH)** has lipolytic effects, meaning it promotes the breakdown of fats to provide energy. - GH typically **stimulates HSL activity** and increases the release of free fatty acids from adipocytes. *ACTH* - **Adrenocorticotropic hormone (ACTH)** primarily stimulates the adrenal cortex to produce cortisol. - **Cortisol** can have lipolytic effects in certain contexts and does not directly inhibit HSL; instead, catecholamines act as direct stimulators of HSL.

Q: Which of the following is a true difference between gangliosides and cerebrosides?

Charge difference. ***Charge difference*** - **Gangliosides** contain **sialic acid (N-acetylneuraminic acid)** residues, which are negatively charged, making gangliosides **anionic**. - **Cerebrosides** are **neutral glycosphingolipids** as they lack charged sugar residues. *Specific carbohydrate composition* - While both have carbohydrate components, referring to "specific carbohydrate composition" as the *true difference* is too broad. Both have characteristic sugar groups, but the **presence of sialic acid** in gangliosides is the key differentiator in charge. - Cerebrosides typically contain a single sugar (either glucose or galactose), whereas gangliosides have a more complex oligosaccharide chain including sialic acid. *Presence of glucose* - Both cerebrosides (specifically **glucocerebrosides**) and gangliosides can contain **glucose** in their carbohydrate moieties. - This is not a distinguishing feature; the *type* and *arrangement* of sugars, particularly the presence of sialic acid, are more specific. *Location in the nervous system* - Both gangliosides and cerebrosides are abundant in the **nervous system**, particularly in cell membranes. - Their presence in the nervous system is a similarity, not a differentiating factor.

Question 1

Which lipoprotein level is affected by LCAT deficiency?

Accepted Answer

HDL

Answer

LDL

Answer

VLDL

Answer

Chylomicron

Question 2

What is the metabolic abnormality associated with Zellweger syndrome?

Accepted Answer

Accumulation of very long-chain fatty acids

Answer

Accumulation of long-chain fatty acids

Answer

Accumulation of short-chain fatty acids

Answer

Accumulation of medium-chain fatty acids

Question 3

Which of the following is a lipotropic factor?

Accepted Answer

Methionine

Answer

Sphingomyelin

Answer

Histidine

Answer

Bilirubin

Question 4

Why is oxidized LDL considered more atherogenic?

Accepted Answer

Is taken up by scavenger receptors

Answer

Is not recognized by LDL receptors

Answer

Promotes inflammation in arterial walls

Answer

Accumulates in macrophages

Question 5

What is the primary product of fatty acid oxidation (β-oxidation)?

Accepted Answer

Acetyl CoA

Answer

Malonyl CoA

Answer

Ketone bodies

Answer

Cholesterol

Question 6

Which of the following is an ω-6 fatty acid?

Accepted Answer

Linoleic acid

Answer

Cervonic acid

Answer

Alpha linolenic acid

Answer

Elaidic acid

Question 7

The primary site of lipogenesis is:

Accepted Answer

Liver

Answer

Skeletal muscles

Answer

Myocardium

Answer

Lungs

Question 8

Which molecule serves as the ultimate source of acetyl groups for fatty acid synthesis?

Accepted Answer

Acetyl CoA

Answer

Malonyl CoA

Answer

Palmitate

Answer

Citrate

Question 9

Which hormone inhibits hormone-sensitive lipase?

Accepted Answer

Insulin

Answer

GH

Answer

ACTH

Answer

Thyroid hormone

Question 10

Which of the following is a true difference between gangliosides and cerebrosides?

Accepted Answer

Charge difference

Answer

Specific carbohydrate composition

Answer

Location in the nervous system

Answer

Presence of glucose

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?